相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Accumulation of versican and lack of versikine ameliorate acute colitis
Shamima Islam et al.
MATRIX BIOLOGY (2022)
Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice
Zhi Wen et al.
BLOOD (2021)
Dendritic Cells Revisited
Mar Cabeza-Cabrerizo et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
T-bet-dependent ILC1-and NK cell-derived IFN-γ mediates cDC1-dependent host resistance against Toxoplasma gondii
Americo H. Lopez-Yglesias et al.
PLOS PATHOGENS (2021)
The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy
Erin E. Peterson et al.
FRONTIERS IN IMMUNOLOGY (2021)
Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
Johanna Bodder et al.
FRONTIERS IN IMMUNOLOGY (2021)
The subunits of IL-12, originating from two distinct cells, can functionally synergize to protect against pathogen dissemination in vivo
Allison N. Gerber et al.
CELL REPORTS (2021)
Spatial Mapping and Immunomodulatory Role of the OX40/OX40L Pathway in Human Non-Small Cell Lung Cancer
Angelo Porciuncula et al.
CLINICAL CANCER RESEARCH (2021)
Fate mapping of single NK cells identifies a type 1 innate lymphoid-like lineage that bridges innate and adaptive recognition of viral infection
Sophie Flommersfeld et al.
IMMUNITY (2021)
Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer
Raphael Mattiuz et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Accumulation of versican facilitates wound healing: Implication of its initial ADAMTS-cleavage site
Shamima Islam et al.
MATRIX BIOLOGY (2020)
Preclinical murine tumor models: a structural and functional perspective
Marion V. Guerin et al.
ELIFE (2020)
Pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver oligometastatic MSS/MMR proficient colorectal cancer (CRC).
Dustin A. Deming et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments.
Philip Emmerich et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation
Thomas N. Wight et al.
FRONTIERS IN IMMUNOLOGY (2020)
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer
Margaux Hubert et al.
SCIENCE IMMUNOLOGY (2020)
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Jeffrey H. Lin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Versican and Versican-matrikines in Cancer Progression, Inflammation, and Immunity
Athanasios Papadas et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
cDC1 prime and are licensed by CD4+T cells to induce anti-tumour immunity
Stephen T. Ferris et al.
NATURE (2020)
Adipocyte-Derived Versican and Macrophage-Derived Biglycan Control Adipose Tissue Inflammation in Obesity
Chang Yeop Han et al.
CELL REPORTS (2020)
Versican: A Dynamic Regulator of the Extracellular Matrix
Shamima Islam et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2020)
CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer
Man Zhang et al.
NATURE COMMUNICATIONS (2020)
CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function
Nicholas F. Kuhn et al.
NATURE COMMUNICATIONS (2020)
Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s
Takaaki Oba et al.
NATURE COMMUNICATIONS (2020)
Context-dependent bioactivity of versican fragments
Katherine Payne Timms et al.
GLYCOBIOLOGY (2020)
Role of ADAMTS-5 in Aortic Dilatation and Extracellular Matrix Remodeling
Marika Fava et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
NKp46 Receptor-Mediated Interferon-γ Production by Natural Killer Cells Increases Fibronectin 1 to Alter Tumor Architecture and Control Metastasis (vol 48, pg 107, 2018)
Ariella Glasner et al.
IMMUNITY (2018)
The fibrotic tumor stroma
Mitsuo Yamauchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments
Kevin C. Barry et al.
NATURE MEDICINE (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy
Jean-David Fumet et al.
BRITISH JOURNAL OF CANCER (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Versican-Derived Matrikines Regulate Batf3-Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer
Chelsea Hope et al.
JOURNAL OF IMMUNOLOGY (2017)
Provisional matrix: A role for versican and hyaluronan
Thomas N. Wight
MATRIX BIOLOGY (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses
Yonit Lavin et al.
CELL (2017)
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
Alfonso R. Sanchez-Paulete et al.
CANCER DISCOVERY (2016)
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
Chelsea Hope et al.
BLOOD (2016)
IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively
Dorine Sichien et al.
IMMUNITY (2016)
Expansion and Activation of CD103+ Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
Helene Salmon et al.
IMMUNITY (2016)
Bioactive extracellular matrix fragments in lung health and disease
Amit Gaggar et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Analyzing CRISPR genome-editing experiments with CRISPResso
Luca Pinello et al.
NATURE BIOTECHNOLOGY (2016)
State-of-the-art of regulatory dendritic cells in cancer
Jose R. Conejo-Garcia et al.
PHARMACOLOGY & THERAPEUTICS (2016)
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
Damya Laoui et al.
NATURE COMMUNICATIONS (2016)
Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer
Dong-Qiang Zeng et al.
ONCOTARGET (2016)
ADAMTS5 Is a Critical Regulator of Virus-Specific T Cell Immunity
Meagan McMahon et al.
PLOS BIOLOGY (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Toll-like Receptor 2 Activation Promotes Tumor Dendritic Cell Dysfunction by Regulating IL-6 and IL-10 Receptor Signaling
Michael Tang et al.
CELL REPORTS (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer
Suniti Misra et al.
FRONTIERS IN IMMUNOLOGY (2015)
TPL2 kinase regulates the inflammatory milieu of the myeloma niche
Chelsea Hope et al.
BLOOD (2014)
Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow
Christian Thomas Mayer et al.
BLOOD (2014)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity (vol 26, pg 638, 2014)
Miranda L. Broz et al.
CANCER CELL (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease
Mary Y. Chang et al.
MATRIX BIOLOGY (2014)
The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis
Sumeda Nandadasa et al.
MATRIX BIOLOGY (2014)
Harnessing human cross-presenting CLEC9A+XCR1+ dendritic cells for immunotherapy
Kirsteen M. Tullett et al.
FRONTIERS IN IMMUNOLOGY (2014)
Flow Cytometric Analysis of Macrophages and Dendritic Cell Subsets in the Mouse Lung
Alexander V. Misharin et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Jeremy D. Waight et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
Melissa G. Lechner et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
GM-CSF Controls Nonlymphoid Tissue Dendritic Cell Homeostasis but Is Dispensable for the Differentiation of Inflammatory Dendritic Cells
Melanie Greter et al.
IMMUNITY (2012)
Inflammation Amplification by Versican: The First Mediator
Zhenwei Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration
Stephen P. Evanko et al.
MATRIX BIOLOGY (2012)
Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research
Silvia A. Fuertes Marraco et al.
FRONTIERS IN IMMUNOLOGY (2012)
Pericellular Versican Regulates the Fibroblast-Myofibroblast Transition A ROLE FOR ADAMTS5 PROTEASE-MEDIATED PROTEOLYSIS
Noriko Hattori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Type I Interferon Drives Dendritic Cell Apoptosis via Multiple BH3-Only Proteins following Activation by PolyIC In Vivo
Silvia A. Fuertes Marraco et al.
PLOS ONE (2011)
Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
Elizabeth D. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Recruitment and Differentiation of Conventional Dendritic Cell Precursors in Tumors
Jun Diao et al.
JOURNAL OF IMMUNOLOGY (2010)
Versican expression is associated with tumor-infiltrating CD8-positive T cells and infiltration depth in cervical cancer
Arko Gorter et al.
MODERN PATHOLOGY (2010)
ADAMTS Metalloproteases Generate Active Versican Fragments that Regulate Interdigital Web Regression
Daniel R. McCulloch et al.
DEVELOPMENTAL CELL (2009)
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
David A. Barbie et al.
NATURE (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity
Kai Hildner et al.
SCIENCE (2008)
HCOP: a searchable database of human orthology predictions
Tina A. Eyre et al.
BRIEFINGS IN BIOINFORMATICS (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFβ1 in prostate cells:: Relevance to the accumulation of versican
NA Cross et al.
PROSTATE (2005)
分享论文
